GENE ONLINE|News &
Opinion
Blog

Go Prime
Coexistence of Thrombophilic Factors and Hemophilia – A Blessing in Disguise?
2020-12-18
Spotlight: Alphafold Maybe This Century’s Biggest Breakthrough in Computational Biology
2020-12-11
2020-China’s Biomedicine Industry Ushers New Upsurge of IPO listings
2020-12-07
Combining the Power of miRNAs and Nanotechnology to Prevent Osteoarthritis Progression
2020-09-27
Spotlight: Cannabidiol (CBD) Based Medication Heralds New Promise in Neurological Therapies
2020-09-22
Exploring RNA Splicing as a Potential New Drug Avenue for Parkinson’s Disease
2020-09-16
Spotlight: Infusion-Related Reactions Associated with Rapid Infusion of Daratumumab
2020-08-31
USFDA Chief Apologizes For Overstating Benefits of Convalescent Plasma Therapy
2020-08-26
A Novel Tool to Augment Checkpoint Inhibitor Cancer Therapy
2020-08-19
R&D
Altering the Treatment Landscape of Neurodegenerative Diseases Using Antisense Oligonucleotides (ASOs)
2020-08-17
Spotlight: New Gene Therapies on the Horizon for the Treatment of Neurogenetic Diseases
2020-08-03
The Rise of Asia as a Destination of Biotech Investment and Opportunity
2020-07-27Partner
A New Paradigm in Biotech Innovation and Investment
2020-07-24Partner
Spotlight: Roche’s SMA Drug, Risdiplam Makes Strong Case for Regulatory Approval
2020-07-05
GeneOnline’s Top Mergers and Acquisitions of 2019
2019-12-31
1 8 9 10 11
LATEST
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top